Molecular Endocrinology, Vol 7, 291-302, Copyright © 1993 by Endocrine Society

ARTICLES

Transcriptional activation of the insulin-like growth factor-II gene during myoblast differentiation

K Kou and P Rotwein
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

Insulin-like growth factor-II (IGF-II) is a secreted 67-amino acid peptide that functions principally as a prenatal growth regulator in mammals. To date, the mechanisms involved in the stimulation of IGF-II expression in the embryo and its attenuation after birth are unknown. Recent studies have shown that IGF-II mRNA and protein are induced during the terminal stages of muscle development in vitro, and that IGF- II may act as an autocrine differentiation agent for skeletal myoblasts. We now have investigated the regulation of IGF-II gene expression in muscle cells. Steady state levels of IGF-II mRNA increased by more than 30-fold during terminal differentiation of the C2 mouse myoblast cell line. Transcription run-on experiments using isolated muscle cell nuclei and direct analysis of nuclear RNA each demonstrated a greater than 10-fold rise in nascent IGF-II mRNA during cellular differentiation, and ribonuclease protection experiments showed that more than 95% of IGF-II mRNAs initiated in noncoding exon 3, implying that transcriptional activation occurs principally through promoter 3, the most 3' of the three mouse IGF-II gene promoters. Analysis of chromatin structure around the IGF-II gene in C2 cells revealed four major and four minor DNase-I-hypersensitive sites, but did not provide insight into the mechanisms of gene activation, since all sites were present in proliferating and differentiating cells. Gene transfer experiments showed that promoter 3 was at least 50-fold more active than promoter 1 or 2 in C2 cells, but the functional assessment of nearly 26 kilobases of additional DNA within the IGF-II locus by an "enhancer trap" approach did not delineate any chromosomal regions capable of mediating differentiation-specific gene activation. Our results demonstrate that muscle cells encode mechanisms for activating IGF-II gene transcription and suggest that these cells may be excellent models for identifying the developmentally regulated factors that control IGF-II gene expression.

This article has been cited by other articles:

				M.-S. Yoon and J. Chen PLD regulates myoblast differentiation through the mTOR-IGF2 pathway J. Cell Sci., February 1, 2008; 121(3): 282 - 289. [Abstract] [Full Text] [PDF]

				E. M. Wilson and P. Rotwein Control of MyoD Function during Initiation of Muscle Differentiation by an Autocrine Signaling Pathway Activated by Insulin-like Growth Factor-II J. Biol. Chem., October 6, 2006; 281(40): 29962 - 29971. [Abstract] [Full Text] [PDF]

				E. Erbay, I.-H. Park, P. D. Nuzzi, C. J. Schoenherr, and J. Chen IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients J. Cell Biol., December 8, 2003; 163(5): 931 - 936. [Abstract] [Full Text] [PDF]

				E. M. Wilson, M. M. Hsieh, and P. Rotwein Autocrine Growth Factor Signaling by Insulin-like Growth Factor-II Mediates MyoD-stimulated Myocyte Maturation J. Biol. Chem., October 17, 2003; 278(42): 41109 - 41113. [Abstract] [Full Text] [PDF]

				Y. Yoshiko, K. Hirao, and N. Maeda Differentiation in C2C12 myoblasts depends on the expression of endogenous IGFs and not serum depletion Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1278 - C1286. [Abstract] [Full Text] [PDF]

				M. Carrasco, J. Canicio, M. Palacin, A. Zorzano, and P. Kaliman Identification of Intracellular Signaling Pathways that Induce Myotonic Dystrophy Protein Kinase Expression during Myogenesis Endocrinology, August 1, 2002; 143(8): 3017 - 3025. [Abstract] [Full Text] [PDF]

				A. J. Forhead, J. Li, R. S. Gilmour, M. J. Dauncey, and A. L. Fowden Thyroid hormones and the mRNA of the GH receptor and IGFs in skeletal muscle of fetal sheep Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E80 - E86. [Abstract] [Full Text] [PDF]

				M. I. Kontaridis, X. Liu, L. Zhang, and A. M. Bennett SHP-2 complex formation with the SHP-2 substrate-1 during C2C12 myogenesis J. Cell Sci., January 6, 2001; 114(11): 2187 - 2198. [Abstract] [Full Text] [PDF]

				Y. Fujio, K. Guo, T. Mano, Y. Mitsuuchi, J. R. Testa, and K. Walsh Cell Cycle Withdrawal Promotes Myogenic Induction of Akt, a Positive Modulator of Myocyte Survival Mol. Cell. Biol., July 1, 1999; 19(7): 5073 - 5082. [Abstract] [Full Text] [PDF]

				P. Kaliman, J. Canicio, X. Testar, M. Palacin, and A. Zorzano Insulin-like Growth Factor-II, Phosphatidylinositol 3-Kinase, Nuclear Factor-kappa B and Inducible Nitric-oxide Synthase Define a Common Myogenic Signaling Pathway J. Biol. Chem., June 18, 1999; 274(25): 17437 - 17444. [Abstract] [Full Text] [PDF]

				J. Canicio, E. Gallardo, I. Illa, X. Testar, M. Palacin, A. Zorzano, and P. Kaliman p70 S6 Kinase Activation Is Not Required for Insulin-Like Growth Factor-Induced Differentiation of Rat, Mouse, or Human Skeletal Muscle Cells Endocrinology, December 1, 1998; 139(12): 5042 - 5049. [Abstract] [Full Text] [PDF]

				P. Kaliman, J. Canicio, P. R. Shepherd, C. A. Beeton, X. Testar, M. Palacín, and A. Zorzano Insulin-like Growth Factors Require Phosphatidylinositol 3-Kinase to Signal Myogenesis: Dominant Negative p85 Expression Blocks Differentiation of L6E9 Muscle Cells Mol. Endocrinol., January 1, 1998; 12(1): 66 - 77. [Abstract] [Full Text]

				J.-F. Hu, T. H. Vu, and A. R. Hoffman Genomic Deletion of an Imprint Maintenance Element Abolishes Imprinting of Both Insulin-like Growth Factor II and H19 J. Biol. Chem., August 15, 1997; 272(33): 20715 - 20720. [Abstract] [Full Text] [PDF]

				J. Ainscough, T Koide, M Tada, S Barton, and M. Surani Imprinting of Igf2 and H19 from a 130 kb YAC transgene Development, January 9, 1997; 124(18): 3621 - 3632. [Abstract] [PDF]

				C. E. H. Stewart and P. Rotwein Insulin-like Growth Factor-II Is an Autocrine Survival Factor for Differentiating Myoblasts J. Biol. Chem., May 10, 1996; 271(19): 11330 - 11338. [Abstract] [Full Text] [PDF]

				D. Montarras, F. Aurade, T. Johnson, J. IIan, F. Gros, and C. Pinset Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage J. Cell Sci., March 1, 1996; 109(3): 551 - 560. [Abstract] [PDF]

				P A Leighton, J R Saam, R S Ingram, C L Stewart, and S M Tilghman An enhancer deletion affects both H19 and Igf2 expression. Genes & Dev., September 1, 1995; 9(17): 2079 - 2089. [Abstract] [PDF]